Avian influenza A (H5N1) infection in humans. by Beigel, J, Farrar, J, Han, A, Hayden, F, Hyer, R, Jong, d, Lochindarat, S, Nguyen, T, Nguyen, T, Tran, T, Nicoll, A, Touch, S, Yuen, K

Transparent development of the WHO rapid advice guidelines. by Schünemann, H, Hill, SR, Kakad, M, Vist, G, Bellamy, R, Stockman, L, Wisløff, T, Del Mar, C, Hayden, F, Uyeki, T, Farrar, J, Yazdanpanah, Y, Zucker, H, Beigel, J, Chotpitayasunondh, T, Hien, T, Ozbay, B, Sugaya, N, Oxman, A

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. by Schünemann, H, Hill, SR, Kakad, M, Bellamy, R, Uyeki, T, Hayden, F, Yazdanpanah, Y, Beigel, J, Chotpitayasunondh, T, Del Mar, C, Farrar, J, Tran, T, Ozbay, B, Sugaya, N, Fukuda, K, Shindo, N, Stockman, L, Vist, G, Croisier, A, Nagjdaliyev, A, Roth, C, Thomson, G, Zucker, H, Oxman, A

SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir by Singh, K, Rubenstein, K, Callier, V, Shaw-Saliba, K, Rupert, A, Dewar, R, Laverdure, S, Highbarger, H, Lallemand, P, Huang, M-L, Jerome, KR, Sampoleo, R, Mills, MG, Greninger, AL, Juneja, K, Porter, D, Benson, CA, Dempsey, W, El Sahly, HM, Focht, C, Jilg, N, Paules, CI, Rapaka, RR, Uyeki, TM, Clifford Lane, H, Beigel, J, Dodd, LE, Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members